These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2610723)
21. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
22. Reduction of LDL production rate in ileal bypassed rabbits treated with lovastatin. Lombardi P; Maggi FM; Maione G; Catapano AL Pharmacol Res; 1991 Feb; 23(2):129-37. PubMed ID: 2062789 [TBL] [Abstract][Full Text] [Related]
23. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K; Sasaki J; Arakawa K Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. Watts GF; Naoumova RP; Kelly JM; Riches FM; Croft KD; Thompson GR Am J Physiol; 1997 Sep; 273(3 Pt 1):E462-70. PubMed ID: 9316434 [TBL] [Abstract][Full Text] [Related]
25. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin. Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637 [TBL] [Abstract][Full Text] [Related]
27. New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase. Tobert JA Circulation; 1987 Sep; 76(3):534-8. PubMed ID: 3113763 [TBL] [Abstract][Full Text] [Related]
28. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients. Branchi A; Rovellini A; Fiorenza AM; Sommariva D Int J Clin Pharmacol Ther; 1995 Jun; 33(6):345-50. PubMed ID: 7582386 [TBL] [Abstract][Full Text] [Related]
29. Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin. Auerbach BJ; Krause BR; Bisgaier CL; Newton RS Atherosclerosis; 1995 Jun; 115(2):173-80. PubMed ID: 7661876 [TBL] [Abstract][Full Text] [Related]
31. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. Pappu AS; Bacon SP; Illingworth DR J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170 [TBL] [Abstract][Full Text] [Related]
32. Lipoprotein fractions and receptors: a role for probucol? Bilheimer DW Am J Cardiol; 1986 Jun; 57(16):7H-15H. PubMed ID: 3637051 [TBL] [Abstract][Full Text] [Related]
33. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells. Nagata Y; Hidaka Y; Ishida F; Kamei T Biochem Pharmacol; 1990 Aug; 40(4):843-50. PubMed ID: 2167097 [TBL] [Abstract][Full Text] [Related]
34. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548 [TBL] [Abstract][Full Text] [Related]
35. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment. Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149 [TBL] [Abstract][Full Text] [Related]
36. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability. Bredie SJ; de Bruin TW; Demacker PN; Kastelein JJ; Stalenhoef AF Am J Cardiol; 1995 Feb; 75(5):348-53. PubMed ID: 7856526 [TBL] [Abstract][Full Text] [Related]
37. Effects of doxazosin, an alpha 1-adrenergic inhibitor, on plasma lipid and lipoprotein levels, low density lipoprotein metabolism and cholesterol absorption in cynomolgus monkeys. Stucchi AF; Vespa DB; Terpstra AH; Nicolosi RJ Atherosclerosis; 1993 Nov; 103(2):255-66. PubMed ID: 8292100 [TBL] [Abstract][Full Text] [Related]
38. Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia. Grundy SM; Vega GL J Lipid Res; 1985 Dec; 26(12):1464-75. PubMed ID: 3853581 [TBL] [Abstract][Full Text] [Related]